Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for autoimmune diseases.

Roberto Furlan1, Erica Butti, Stefano Pluchino

  • 1Neuroimmunology Unit, DIBIT, Department of Neurology and Neurophysiology, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy. furlan.roberto@hsr.it

Current Opinion in Molecular Therapeutics
|November 13, 2004
PubMed
Summary

Gene therapy offers a promising approach to treating autoimmune diseases by targeting affected tissues and interfering with disease progression. This review explores its potential in experimental models of diabetes, rheumatoid arthritis, and multiple sclerosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplant.

Med (New York, N.Y.)·2026
Same author

Extracellular Vesicle-Associated IL4 Displays Enhanced Anti-Inflammatory Properties in Microglial Cells.

Journal of extracellular biology·2026
Same author

Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry.

AIDS (London, England)·2026
Same author

A roadmap for supporting the development of advanced therapy medicinal products in a European framework.

The Lancet regional health. Europe·2026
Same author

Translating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmap.

Clinical chemistry and laboratory medicine·2026
Same author

Duloxetine ameliorates cerebral ischemic injury by inhibiting autophagy.

Autophagy·2026

Area of Science:

  • Immunology
  • Genetics
  • Therapeutics

Background:

  • Autoimmune diseases are a growing global health concern, causing significant disability and societal costs.
  • Current treatments primarily manage symptoms, with limited impact on disease progression or physical impairment.
  • Novel therapeutic strategies are urgently needed to address the limitations of existing treatments.

Purpose of the Study:

  • To review gene therapy as a potential alternative treatment for autoimmune disorders.
  • To highlight gene therapy's capacity for targeted tissue intervention and pathogenic process modulation.
  • To examine functional replacement and reparative mechanisms facilitated by gene therapy.

Main Methods:

  • Review of existing literature on gene therapy for autoimmune diseases.

Related Experiment Videos

  • Focus on studies utilizing experimental models of specific autoimmune conditions.
  • Analysis of gene therapy's efficacy in targeting autoimmune aggression and promoting repair.

    • Main Results:

    • Gene therapy demonstrates potential for specific targeting of autoimmune-affected tissues.
    • It can interfere with destructive pathogenic processes in autoimmune diseases.
    • Studies in experimental models show promise for functional replacement and fostering repair.

    Conclusions:

    • Gene therapy presents a viable alternative strategy for managing autoimmune diseases.
    • Its ability to target specific tissues and modulate disease processes is a key advantage.
    • Further research in experimental models of diabetes, rheumatoid arthritis, and multiple sclerosis supports its therapeutic potential.